Panel Discussion | Forthcoming Pathways in Interventional Cardiology

Monday, February 27, 2023

3:30 PM – 3:45 PM ET

Panel Moderator(s)

Nabil Dib, MD, MSc, FACC

Director Cardiovascular Research
Mercy Gilbert Medical Center/Dignity Health
Gilbert, Arizona, United States

Disclosure(s): AstraZeneca Pharmaceuticals: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated)
Spencer B. King, III, MD, MACC, MSCAI

Professor of Medicine Emeritus
Emory University
Atlanta, Georgia, United States

No relationships to disclose
Ron Waksman, MD, MSCAI

Director, Cardiovascular Research and Advanced Education
MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
Washington, District of Columbia, United States

Disclosure information not submitted.

Panel Discussant(s)

Todd J. Brinton, MD

Chief Scientific Officer
Edwards Lifesciences
Irvine, California, United States

No relationships to disclose
Anthony DeMaria, MD

Judy and Jack White Chair in Cardiology
University of California, San Diego
La Jolla, California, United States

Disclosure(s): Hitachi: Equipement grant (Ongoing)
C. Michael Gibson, MD

Professor of Medicine
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States

Disclosure(s): Absolutys: Shareholder (Ongoing); Angel Medical Systems, Inc.: Consultant (Ongoing); AstraZeneca Pharmaceuticals: Consultant (Ongoing); Bayer HealthCare: Consultant (Ongoing); Bioclinica: Consultant (Ongoing); Boston Clinical Research Institute: Consultant (Ongoing), Owner/Co-Owner Founder/Co-Founder (Ongoing); Boston Scientific: Consultant (Ongoing); Bristol Meyers Squibb: Consultant (Ongoing); Caladrius Bioscience: Consultant (Ongoing); Cardiovascular Research Foundation: Consultant (Ongoing); CeleCor Therapeutics: Consultant (Ongoing); CSL-Behring: Consultant (Ongoing), Grant/Research Support (Ongoing); Cytokinetics: Consultant (Ongoing); Daiichi Sankyo, Inc.: Consultant (Ongoing); Duke Clinical Research Institute: Consultant (Ongoing); Dyad Medical: Shareholder (Ongoing); EXCITE International: Advisor (Ongoing); Fortress Biotech: Consultant (Ongoing), Shareholder (Ongoing); Gilead: Consultant (Ongoing); Inari: Consultant (Ongoing); Janssen Research & Development LLC: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Johnson & Johnson: Consultant (Ongoing), Grant/Research Support (Ongoing); MashUP MD: Consultant (Ongoing); MD Magazine: Consultant (Ongoing); MedImmune: Consultant (Ongoing); Medtelligence: Consultant (Ongoing); Merck Pharmaceuticals: Consultant (Ongoing); Microdrop: Consultant (Ongoing); MicroPort Medical: Consultant (Ongoing); Miracor: Consultant (Ongoing); MJH Life Sciences: Consultant (Ongoing); nference: Shareholder (Ongoing); Novartis Pharmaceuticals: Consultant (Ongoing); NovoNordisk: Consultant (Ongoing); Paratek: Consultant (Ongoing); PERT Consortium: Consultant (Ongoing); Pfizer: Consultant (Ongoing); PhaseBio: Consultant (Ongoing); plx pharma: Consultant (Ongoing); Revance Therapeutics: Consultant (Ongoing); Solstic Health/New Amsterdam Pharma: Consultant (Ongoing); Somahlution/Marizyme: Consultant (Ongoing); UpToDate in Cardiovascular Medicine: Royalties (Ongoing); Vecutra: Consultant (Ongoing); WebMD: Consultant (Ongoing); Woman As One: Consultant (Ongoing)
A Pieter Kappetein, MD, PhD (he/him/his)

Prof
Medtronic
Rotterdam, Netherlands

Disclosure(s): medtronic: Salary (Ongoing), Shareholder (Ongoing)
Stanton J. Rowe

CEO
NXT Biomedical
Irvine, California, United States

Disclosure(s): Anuncia Medical: Board Member (Ongoing), Board Member/Officer/Trustee (Ongoing), Stock-privately held company (Ongoing); NovaSignal Corp: Board Member (Ongoing), Board Member/Officer/Trustee (Ongoing), Shareholder (Ongoing); NXT Biomedical Biomedical: Board Member (Ongoing), Board Member/Officer/Trustee (Ongoing), Employee (Ongoing), Shareholder (Ongoing), Stock-privately held company (Ongoing)
Charles A. Simonton, MD, FACC, FSCAI

EVP Chief Medical Officer
Abiomed Inc
Charlotte, North Carolina, United States

Disclosure(s): Abiomed: Employee (Ongoing)
JS

John B. Simpson, MD

Disclosure information not submitted.
Gregg W. Stone, MD, FACC, MSCAI (he/him/his)

Physician
Mount Sinai
New York, New York, United States

Disclosure(s): Abbott, Abiomed, Bioventrix, Cardiovascular Systems Inc, Phillips, Biosense-Webster, Shockwave, Vascular Dynamics, Pulnovo and V-wave: University Grants/Research Support (Ongoing); Abiomed, CorFlow, Apollo Therapeutics, Cardiomech, Gore, Amgen, Millennia Biopharma: Consultant (Terminated); Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Cardiac Success, Valfix, Xenter: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); Medtronic, Pulnovo, Infraredx: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Valfix, TherOx, Robocath, HeartFlow, Ablative Solutions, Miracor, Neovasc, Ancora, Vectorious, Elucid Bio, Occlutech, Impulse Dynamics, Adona Medical: Consultant (Ongoing)
Bram Zuckerman, MD

Director Office of CV Devices
U.S. Food and Drug Administration
Silver Spring, Maryland, United States

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Nabil Dib, MD, MSc, FACC: AstraZeneca Pharmaceuticals: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated)

Anthony DeMaria, MD: Hitachi: Equipement grant (Ongoing)

C. Michael Gibson, MD: Absolutys: Shareholder (Ongoing); Angel Medical Systems, Inc.: Consultant (Ongoing); AstraZeneca Pharmaceuticals: Consultant (Ongoing); Bayer HealthCare: Consultant (Ongoing); Bioclinica: Consultant (Ongoing); Boston Clinical Research Institute: Consultant (Ongoing), Owner/Co-Owner Founder/Co-Founder (Ongoing); Boston Scientific: Consultant (Ongoing); Bristol Meyers Squibb: Consultant (Ongoing); Caladrius Bioscience: Consultant (Ongoing); Cardiovascular Research Foundation: Consultant (Ongoing); CeleCor Therapeutics: Consultant (Ongoing); CSL-Behring: Consultant (Ongoing), Grant/Research Support (Ongoing); Cytokinetics: Consultant (Ongoing); Daiichi Sankyo, Inc.: Consultant (Ongoing); Duke Clinical Research Institute: Consultant (Ongoing); Dyad Medical: Shareholder (Ongoing); EXCITE International: Advisor (Ongoing); Fortress Biotech: Consultant (Ongoing), Shareholder (Ongoing); Gilead: Consultant (Ongoing); Inari: Consultant (Ongoing); Janssen Research & Development LLC: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Johnson & Johnson: Consultant (Ongoing), Grant/Research Support (Ongoing); MashUP MD: Consultant (Ongoing); MD Magazine: Consultant (Ongoing); MedImmune: Consultant (Ongoing); Medtelligence: Consultant (Ongoing); Merck Pharmaceuticals: Consultant (Ongoing); Microdrop: Consultant (Ongoing); MicroPort Medical: Consultant (Ongoing); Miracor: Consultant (Ongoing); MJH Life Sciences: Consultant (Ongoing); nference: Shareholder (Ongoing); Novartis Pharmaceuticals: Consultant (Ongoing); NovoNordisk: Consultant (Ongoing); Paratek: Consultant (Ongoing); PERT Consortium: Consultant (Ongoing); Pfizer: Consultant (Ongoing); PhaseBio: Consultant (Ongoing); plx pharma: Consultant (Ongoing); Revance Therapeutics: Consultant (Ongoing); Solstic Health/New Amsterdam Pharma: Consultant (Ongoing); Somahlution/Marizyme: Consultant (Ongoing); UpToDate in Cardiovascular Medicine: Royalties (Ongoing); Vecutra: Consultant (Ongoing); WebMD: Consultant (Ongoing); Woman As One: Consultant (Ongoing)

A Pieter Kappetein, MD, PhD: medtronic: Salary (Ongoing), Shareholder (Ongoing)

Stanton J. Rowe: Anuncia Medical: Board Member (Ongoing), Board Member/Officer/Trustee (Ongoing), Stock-privately held company (Ongoing); NovaSignal Corp: Board Member (Ongoing), Board Member/Officer/Trustee (Ongoing), Shareholder (Ongoing); NXT Biomedical Biomedical: Board Member (Ongoing), Board Member/Officer/Trustee (Ongoing), Employee (Ongoing), Shareholder (Ongoing), Stock-privately held company (Ongoing)

Charles A. Simonton, MD, FACC, FSCAI: Abiomed: Employee (Ongoing)

Gregg W. Stone, MD, FACC, MSCAI: Abbott, Abiomed, Bioventrix, Cardiovascular Systems Inc, Phillips, Biosense-Webster, Shockwave, Vascular Dynamics, Pulnovo and V-wave: University Grants/Research Support (Ongoing); Abiomed, CorFlow, Apollo Therapeutics, Cardiomech, Gore, Amgen, Millennia Biopharma: Consultant (Terminated); Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Cardiac Success, Valfix, Xenter: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); Medtronic, Pulnovo, Infraredx: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Valfix, TherOx, Robocath, HeartFlow, Ablative Solutions, Miracor, Neovasc, Ancora, Vectorious, Elucid Bio, Occlutech, Impulse Dynamics, Adona Medical: Consultant (Ongoing)

Bram Zuckerman, MD: No financial relationships to disclose